Megakaryocyte miR-125a-5p positively regulates proplatelet formation and platelet number by targeting the actin-bundling protein L-plastin.
L-plastin regulates megakaryocyte migration, proplatelet branching, podosome formation and invagination membrane system development.
There is heritability to inter-individual variation in platelet count, and better understanding of the regulating genetic factors may provide insights for thrombopoiesis. MicroRNAs (miRs) regulate gene expression in health and disease, and megakaryocytes (MKs) deficient in miRs have lower platelet counts, but there is a limited information about the role of miRs in normal human MK and platelet production. Using genome-wide miR profiling, we observed strong correlations among human bone marrow MKs, platelets and differentiating cord blood-derived MK cultures, and identified MK miR-125a-5p as associated with human platelet number but not leukocyte or hemoglobin levels. Overexpression and knock-down studies showed miR-125a-5p positively regulated human MK proplatelet (PP) formation in vitro. Inhibition of miR-125a-5p in vivo lowered murine platelet counts. Analyses of MK and platelet transcriptomes identified LCP1 as a miR-125a-5p target. LCP1 encodes the actin-bundling protein, L-plastin, not previously studied in MKs. We show miR-125a-5p directly targets and reduces expression of MK L-plastin. Overexpression and knock-down studies show L-plastin promotes MK progenitor migration, but negatively correlates with human platelet count and inhibits MK PP formation. This work provides the first evidence for the actin-bundling protein, L-plastin, as a regulator of human MK PP formation via inhibition of the late-stage MK invagination system, podosome and PP formation, and PP branching. We also provide resources of primary and differentiating MK transcriptomes and miRs associated with platelet counts. miR-125a-5p and L-plastin may be relevant targets for increasing in vitro platelet manufacturing and for managing quantitative platelet disorders.